These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Criteria for the appropriate drug utilisation of immunoglobulin. Thürmann P; Harder S Pharmacoeconomics; 1996 May; 9(5):417-29. PubMed ID: 10160254 [TBL] [Abstract][Full Text] [Related]
24. [Splenectomy in adult patients with idiopathic thrombocytopenic purpura after intravenous immunoglobulin treatment]. Nowak T; Kucharski W; Scharf R Acta Haematol Pol; 1994; 25(1):31-5. PubMed ID: 8209611 [TBL] [Abstract][Full Text] [Related]
25. Cerebral infarctions after intravenous immunoglobulin therapy for ITP in a child. Lorenzana A; Armin S; Sharma A; Allarakhia I; Witkowski A Pediatr Neurol; 2014 Feb; 50(2):188-91. PubMed ID: 24262342 [TBL] [Abstract][Full Text] [Related]
26. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura. Ruggeri M; Castaman G; De Nardi G; Rodeghiero F Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of immunoglobulin retreatment in Kawasaki disease. Falcini F; Ermini M; Trapani S; Taccetti G J Pediatr; 1994 Oct; 125(4):672-3. PubMed ID: 7931898 [No Abstract] [Full Text] [Related]
28. Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin. Sullivan KM Clin Ther; 1996; 18 Suppl B():126-36. PubMed ID: 8930450 [TBL] [Abstract][Full Text] [Related]
29. The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease. Kaneka K; Savage CO; Pottinger BE; Shah V; Pearson JD; Dillon MJ Pediatr Infect Dis J; 1994 Nov; 13(11):1022-3. PubMed ID: 7845731 [No Abstract] [Full Text] [Related]
30. Acute aseptic meningitis secondary to intravenous immunoglobulin in a patient with Kawasaki syndrome. Boyce TG; Spearman P Pediatr Infect Dis J; 1998 Nov; 17(11):1054-6. PubMed ID: 9849996 [No Abstract] [Full Text] [Related]
31. [Use of intravenous immunoglobulins in pediatrics]. Duse M; Plebani A; Crispino P; Ugazio AG Pediatr Med Chir; 1991; 13(2):117-25. PubMed ID: 1896376 [TBL] [Abstract][Full Text] [Related]
32. VI nerve palsy after intravenous immunoglobulin in Kawasaki disease. Rodríguez-Lozano A; Juárez-Echenique JC; Rivas-Larrauri F; Gámez-González LB; Yamazaki-Nakashimada M Allergol Immunopathol (Madr); 2014; 42(1):82-3. PubMed ID: 23340202 [No Abstract] [Full Text] [Related]
33. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies. Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733 [TBL] [Abstract][Full Text] [Related]
34. Recommendations for intravenous immunoglobulin therapy of Kawasaki disease. Shulman ST Pediatr Infect Dis J; 1992 Nov; 11(11):985-6. PubMed ID: 1454455 [No Abstract] [Full Text] [Related]
35. Aseptic meningitis due to administration of intravenous immunoglobulin with an unusually high number of leukocytes in cerebrospinal fluid. Obando I; Duran I; Martin-Rosa L; Cano JM; Garcia-Martin FJ Pediatr Emerg Care; 2002 Dec; 18(6):429-32. PubMed ID: 12488836 [No Abstract] [Full Text] [Related]
40. Use of intravenous gammaglobulin as an immune replacement and an immune suppressant. Boshkov LK; Kelton JG Transfus Med Rev; 1989 Apr; 3(2):82-120. PubMed ID: 2520551 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]